Skip to main content Skip to section navigation Skip to footer
Back to AchieveLifeSciences.com
Achieve Life Sciences, Inc. Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 17, 2019 1:06pm EST

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

Dec 09, 2019 5:30am EST

Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program

Nov 06, 2019 6:30am EST

Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

Oct 31, 2019 5:30am EDT

Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019

Oct 24, 2019 5:30am EDT

Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference

Sep 30, 2019 5:30am EDT

Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study

Sep 13, 2019 5:30am EDT

Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

Sep 05, 2019 5:30am EDT

Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial

Sep 04, 2019 5:30am EDT

Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences

Aug 08, 2019 5:39pm EDT

/C O R R E C T I O N -- Achieve Life Sciences, Inc./

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • …Page 15
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2022 Achieve Life Sciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap